Longeveron reports topline results from ELPIS II Phase 2b
Headline indicates topline results from ELPIS II Phase 2b evaluating laromestrocel for hypoplastic left heart syndrome (HLHS).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.